News | October 08, 2025
Lupin to build $250 million manufacturing facility in Florida
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The facility has been classified as Voluntary Action Indicated
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Subscribe To Our Newsletter & Stay Updated
